Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bluebird Bio
Bluebird Bio
bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y
Yahoo/Zacks.com
Sat, 02/23/19 - 04:03 pm
Bluebird Bio
earnings
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Biogen
Bluebird Bio
Global Blood Therapeutics
Aimmune Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Where Will bluebird bio Be in 5 Years?
Motley Fool
Thu, 01/24/19 - 11:41 am
Bluebird Bio
LentiGlobin
bb21217
CAR-T
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Celgene
M&A
Juno Therapeutics
Kite Therapeutics
Bluebird Bio
Agios Pharmaceuticals
Jounce Therapeutics
BieGene
Acceleron
bluebird's five-year pricing model for LentiGlobin could resonate with payers
BioCentury
Wed, 01/9/19 - 09:21 am
Bluebird Bio
LentiGlobin
Medicaid
drug pricing
payers
Here's Why bluebird bio Shares Got Knocked Down 19.3% in December
Motley Fool
Sat, 01/5/19 - 12:05 am
Bluebird Bio
ASH2018
AMG 420
Amgen
Six Things to Watch for at the JP Morgan Healthcare Conference
BioSpace
Fri, 01/4/19 - 10:35 am
Moderna Therapeutics
Sarepta Therapeutics
Biogen
Gilead Sciences
Bluebird Bio
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Motley Fool
Wed, 12/5/18 - 11:54 am
Celgene
Bluebird Bio
bb21217
ASH18: New data can’t lift Bluebird Bio’s depressed shares
Fierce Biotech
Tue, 12/4/18 - 10:02 am
Bluebird Bio
ASH 2018
ASH18: Bluebird's follow-on CAR-T finds initial success, but durability will be key test
Biopharma Dive
Sun, 12/2/18 - 10:50 pm
ASH2018
Bluebird Bio
CAR-T
bb21217
Top Biotech Stocks to Watch at ASH 2018
Yahoo/Motley Fool
Sun, 12/2/18 - 12:37 pm
ASH2018
Celgene
Bluebird Bio
Acceleron
Waiting for bluebird bio to Sing at ASH
Motley Fool
Sat, 11/10/18 - 12:05 pm
Bluebird Bio
earnings
ASH
CAR-T
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Acceleron
luspatercept
Bluebird Bio
bb21217
Amgen
AMG 420
Here's Why bluebird bio Dropped 13.3% in September
Motley Fool
Thu, 10/11/18 - 10:54 pm
Bluebird Bio
Amgen
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
CP Wire
Fri, 10/5/18 - 09:50 am
Bluebird Bio
transfusion-dependent anemia
LentiGlobin
EMA
Europe
EMA Accepts Bluebird Bio's Marketing Authorization Application for Gene Therapy for Rare Blood Disorder
Fri, 10/5/18 - 09:18 am
Bluebird Bio
transfusion-dependent anemia
LentiGlobin
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Bluebird Bio
Amgen
Celgene
AMG-420
bb2121
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Thu, 08/23/18 - 11:04 am
Bluebird Bio
Gritstone Oncology
oncology
T-cell receptors
drug development
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »